CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-24 | Freund John Gordon Director | Grant or award | +2,253 | 2,253 | ||
| 2018-05-24 | Freund John Gordon Director | Grant or award · Stock Option (Right to Purchase) | +4,506 | 4,506 | ||
| 2018-05-24 | Hirsch David Director | Grant or award | +2,253 | 27,193 | ||
| 2018-05-24 | Hirsch David Director | Grant or award · Stock Option (Right to Purchase) | +4,506 | 4,506 | ||
| 2018-05-24 | SANTINI GINO Director | Grant or award | +2,253 | 25,441 | ||
| 2018-05-24 | SANTINI GINO Director | Grant or award · Stock Option (Right to Purchase) | +4,506 | 4,506 | ||
| 2018-05-10 | Fleming Alison B Chief Technical Officer | Sale | −1,400 | $27.00 | $38K | 154,764 |
| 2018-05-10 | Heffernan Michael Thomas Chairman, President and CEO | Sale | −5,600 | $26.00 | $146K | 540,193 |
| 2018-05-10 | Heffernan Michael Thomas Chairman, President and CEO | Sale | −1,500 | $27.00 | $41K | 538,693 |
| 2018-04-19 | Heffernan Michael Thomas Chairman, President and CEO | Sale | −44,300 | $26.00 | $1.2M | 545,893 |
| 2018-04-19 | Heffernan Michael Thomas Chairman, President and CEO | Sale | −100 | $26.01 | $3K | 545,793 |
| 2018-04-04 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +20,000 | 20,000 | ||
| 2018-04-04 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award · Stock Option (Right to Purchase) | +40,000 | 40,000 | ||
| 2018-04-02 | Fleming Alison B Chief Technology Officer | Option exercise | +4,225 | $0.28 | $1K | 53,541 |
| 2018-04-02 | Fleming Alison B Chief Technology Officer | Option exercise | +3,917 | $0.28 | $1K | 57,458 |
| 2018-04-02 | Fleming Alison B Chief Technology Officer | Option exercise · Stock option (right to purchase) | −4,225 | 0 | ||
| 2018-04-02 | Fleming Alison B Chief Technology Officer | Option exercise · Stock option (right to purchase) | −3,917 | 0 | ||
| 2018-01-19 | Fleming Alison B Chief Technical Officer | Option exercise | +64 | $0.90 | $58 | 156,228 |
| 2018-01-19 | Fleming Alison B Chief Technical Officer | Sale | −64 | $23.00 | $1K | 156,164 |
| 2018-01-19 | Fleming Alison B Chief Technical Officer | Option exercise | +1,811 | $0.90 | $2K | 157,975 |
Page 31 of 32 · 635 trades